Reply on "Prognosis according to the timing of recurrence in breast cancer" (Ann Surg Treat Res 2023;104:1-9).
作者信息
Jung Seung Pil, Lee Young Joo, Bae Soo Youn
机构信息
Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Division of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Ann Surg Treat Res. 2024 Apr;106(4):239-240. doi: 10.4174/astr.2024.106.4.239. Epub 2024 Mar 29.
Abstract
摘要
相似文献
1
Reply on "Prognosis according to the timing of recurrence in breast cancer" (Ann Surg Treat Res 2023;104:1-9).对《乳腺癌复发时间的预后分析》（《外科治疗与研究杂志》2023年；104:1-9）的回复
Ann Surg Treat Res. 2024 Apr;106(4):239-240. doi: 10.4174/astr.2024.106.4.239. Epub 2024 Mar 29.
2
Commentary on "Prognosis according to the timing of recurrence in breast cancer" (Ann Surg Treat Res 2023;104:1-9).关于《乳腺癌复发时间与预后》的述评（《外科治疗与研究杂志》2023年；第104卷：第1 - 9页）
Ann Surg Treat Res. 2024 Apr;106(4):237-238. doi: 10.4174/astr.2024.106.4.237. Epub 2024 Mar 29.
3
Reply on "Efficacy of biofeedback therapy for objective improvement of pelvic function in low anterior resection syndrome (Ann Surg Treat Res 2019;97:194-201)".关于“生物反馈疗法对低位前切除术综合征患者盆底功能客观改善的疗效（《外科学治疗与研究》2019年；97:194 - 201）”的回复
Ann Surg Treat Res. 2020 Aug;99(2):129-130. doi: 10.4174/astr.2020.99.2.129. Epub 2020 Jul 31.
4
Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 1997;4(3):198-202.小叶性乳腺癌的双侧性及复发率：治疗考量。《外科肿瘤学杂志》1997年；4(3)：198 - 202。
J Womens Health. 1998 Mar;7(2):265-6. doi: 10.1089/jwh.1998.7.265.
5
Commentary on "Efficacy of biofeedback therapy for objective improvement of pelvic function in low anterior resection syndrome (Ann Surg Treat Res 2019;97:194-201)".关于“生物反馈疗法对低位前切除术综合征患者盆底功能客观改善的疗效（《外科治疗与研究杂志》2019年；97:194 - 201）”的述评
Ann Surg Treat Res. 2020 Aug;99(2):127-128. doi: 10.4174/astr.2020.99.2.127. Epub 2020 Jul 31.
6
Using Size and Grade to Identify Women Aged ≥ 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity : Letter to Editor Reply to "Sized influences nodal status in women aged ≥ 70 with endocrine responsive breast cancer" by Fitzal, Florian et al. in Ann Surg Oncol DOI 10.1245/s10434-017-6156-0.利用肿瘤大小和分级识别年龄≥70岁且淋巴结转移风险低的内分泌反应性乳腺癌女性：致编辑的信——对弗洛里安·菲茨阿尔等人发表于《外科肿瘤学年鉴》（DOI 10.1245/s10434-017-6156-0）上的“肿瘤大小影响年龄≥70岁的内分泌反应性乳腺癌女性的淋巴结状态”一文的回复
Ann Surg Oncol. 2017 Dec;24(Suppl 3):557-558. doi: 10.1245/s10434-017-6158-y. Epub 2017 Oct 30.
7
Reply to "Commentary to Matsuda et al., Ann Surg Oncol (2013) 20:856-863," by Karl Kodeda and Richard J. Heald (doi:10.1245/s10434-013-2951-4).对卡尔·小枝田（Karl Kodeda）和理查德·J·希尔德（Richard J. Heald）所著《对松田等人的评论，《外科肿瘤学年鉴》（2013年）20:856 - 863》的回复（doi:10.1245/s10434 - 013 - 2951 - 4）
Ann Surg Oncol. 2013 Oct;20(11):3704. doi: 10.1245/s10434-013-2952-3. Epub 2013 Mar 24.
8
Potential markers predicting distant metastasis in axillary node-negative breast carcinoma.预测腋窝淋巴结阴性乳腺癌远处转移的潜在标志物。
Int J Cancer. 2002 Apr 10;98(5):754-60. doi: 10.1002/ijc.10136.
9
Paravertebral Blocks Reduce Narcotic Use Without Affecting Perfusion in Patients Undergoing Autologous Breast Reconstruction.椎旁阻滞减少阿片类药物的使用而不影响自体乳房重建患者的灌注。
Ann Surg Oncol. 2017 Oct;24(11):3180-3187. doi: 10.1245/s10434-017-6007-z. Epub 2017 Jul 17.
10
Reply to "Anti-cytokeratin CAM5.2 recognized CK8 mainly, but not CK18: comment on 'Early assessment of axillary response with 18F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla. Ann Surg Oncol. 2013;20(7):2227-35'".对《抗细胞角蛋白CAM5.2主要识别CK8而非CK18：评〈II-III期乳腺癌新辅助化疗期间用18F-FDG PET/CT对腋窝反应的早期评估：对腋窝手术管理的意义。《外科肿瘤学杂志》。2013年；20(7):2227 - 2235〉》的回复
Ann Surg Oncol. 2014 Feb;21(2):700. doi: 10.1245/s10434-013-3273-2. Epub 2013 Sep 20.
引用本文的文献
1
Assessing the recurrence rate in locally advanced Luminal A patients compared to triple-negative patients in Shahid Rahimi Hospital Khorramabad in 2022: a cross-sectional study.2022年在霍拉马巴德沙希德·拉希米医院评估局部晚期管腔A型患者与三阴性患者的复发率：一项横断面研究。
Ann Med Surg (Lond). 2025 May 13;87(6):3123-3127. doi: 10.1097/MS9.0000000000003338. eCollection 2025 Jun.
2
Machine learning-based integration develops relapse related signature for predicting prognosis and indicating immune microenvironment infiltration in breast cancer.基于机器学习的整合开发了与复发相关的特征，用于预测乳腺癌的预后并指示免疫微环境浸润。
Sci Rep. 2025 Jun 5;15(1):19773. doi: 10.1038/s41598-025-03423-8.
本文引用的文献
1
Prognosis according to the timing of recurrence in breast cancer.乳腺癌复发时间的预后情况。
Ann Surg Treat Res. 2023 Jan;104(1):1-9. doi: 10.4174/astr.2023.104.1.1. Epub 2023 Jan 2.
Zotero 插件